Alaris Medical Inc.
Division of Cardinal Health Inc.
Latest From Alaris Medical Inc.
Spine firm NuVasive named Joan Stafslien, previously with CareFusion, as general counsel.
The need for a positive economic argument when introducing a new medtech product is more critical than ever. Management teams are well aware of the need to demonstrate compelling economic data, but can a product still be successful without an economic benefit in the increasingly cost-conscious health care marketplace? Overcoming negative economics means identifying a combination of positive attributes that can overcome the economic barrier, and this thought process should be conducted well before significant R&D funds are invested.
In Vivo presents another installment of our quarterly reivew of dealmaking--in this case July-September 2003. Our data come from Windhover's Strategic Transactions Database. We include medical device financings by deal type; diagnostic financings by industry segment; pharma and biotech alliances by therapeutic category and industry segment; pharma and biotech financings by market segment, and pharma and biotech M&A.
It is not uncommon for a new medical device to fail to initially live up to projected sales expectations. Early disappointing product sales can produce a hole that a company can spend a long time trying to dig its way out of, having to battle a declining stock price, decreased investor confidence, lower company valuations, and diminished access to capital. The end result may be that both the product and the company are never able to fully recover from the early set-back. Many initial disappointing product roll-outs can be attributed to problems that commonly confront device companies. Product companies have adopted successful strategies to anticipate and overcome many of these issues, and thereby increase the chances of a new product coming strong out-of-the blocks.
- Medical Devices
- Therapeutic Areas
- Ivac Corp.
- Advanced Medical Inc.
- North America
- Parent & Subsidiaries
- Cardinal Health Inc.
- Senior Management
David L Schlotterbeck, Pres. & CEO
William C Bopp, SVP & CFO
Anthony B Semedo, VP, Corp. Dev.
Kevin Whiteley, VP, Mktg.
- Contact Info
Alaris Medical Inc.
Phone: (619) 458-7000
10221 Wateridge Circle
San Diego, CA 92121-2733